Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
株式のランク #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
株価
$25.61
最終同期: 2025-10-10
時価総額
$1.37B
変化(1日)
0.20%
変化(1年)
1.59%
US
取引 Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

カテゴリー

Harrow Health, Inc. 8.625% Senior Notes due 2026(HROWL)の配当履歴
Harrow Health, Inc. 8.625% Senior Notes due 2026(証券コード:HROWL)は合計で0回の配当を行いました。
すべての配当の合計(株式分割調整済み)は:0.00
配当利回り(TTM):0
2026から2026までのHarrow Health, Inc. 8.625% Senior Notes due 2026(HROWL)の配当履歴
年間配当支払い
配当(株式分割調整済み) 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴